These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38851812)

  • 1. Correction: Anti-lymphangiogenesis for boosting drug accumulation in tumors.
    Wang C; Xu J; Cheng X; Sun G; Li F; Nie G; Zhang Y
    Signal Transduct Target Ther; 2024 Jun; 9(1):157. PubMed ID: 38851812
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-lymphangiogenesis for boosting drug accumulation in tumors.
    Wang C; Xu J; Cheng X; Sun G; Li F; Nie G; Zhang Y
    Signal Transduct Target Ther; 2024 Apr; 9(1):89. PubMed ID: 38616190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFβ counteracts LYVE-1-mediated induction of lymphangiogenesis by small hyaluronan oligosaccharides.
    Bauer J; Rothley M; Schmaus A; Quagliata L; Ehret M; Biskup M; Orian-Rousseau V; Jackson DG; Pettis RJ; Harvey A; Bräse S; Thiele W; Sleeman JP
    J Mol Med (Berl); 2018 Feb; 96(2):199-209. PubMed ID: 29282520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis.
    Kimura Y; Sumiyoshi M
    Phytomedicine; 2013 Feb; 20(3-4):328-36. PubMed ID: 23219337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between tumors and the lymphatics: what more is there to know?
    Sleeman JP
    Lymphology; 2006 Jun; 39(2):62-8. PubMed ID: 16910096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.
    Ruddell A; Kelly-Spratt KS; Furuya M; Parghi SS; Kemp CJ
    Oncogene; 2008 May; 27(22):3145-55. PubMed ID: 18059331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maladaptive lymphangiogenesis is associated with synovial iron accumulation and delayed clearance in factor VIII-deficient mice after induced hemarthrosis.
    Cooke EJ; Joseph BC; Nasamran CA; Fisch KM; von Drygalski A
    J Thromb Haemost; 2023 Sep; 21(9):2390-2404. PubMed ID: 37116753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors.
    Sipos B; Klapper W; Kruse ML; Kalthoff H; Kerjaschki D; Klöppel G
    Am J Pathol; 2004 Oct; 165(4):1187-97. PubMed ID: 15466385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Extracellular Vesicles on Cancer Lymphangiogenesis and Lymph Node Metastasis.
    Wang L; Li L; Zhu G
    Front Oncol; 2021; 11():721785. PubMed ID: 34552874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis.
    Cao Z; Shang B; Zhang G; Miele L; Sarkar FH; Wang Z; Zhou Q
    Biochim Biophys Acta; 2013 Dec; 1836(2):273-86. PubMed ID: 23933263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity inhibits lymphangiogenesis in prostate tumors.
    Moreira Â; Pereira SS; Machado CL; Morais T; Costa M; Monteiro MP
    Int J Clin Exp Pathol; 2014; 7(1):348-52. PubMed ID: 24427356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats.
    Yazdani S; Hijmans RS; Poosti F; Dam W; Navis G; van Goor H; van den Born J
    Dis Model Mech; 2015 Aug; 8(8):919-30. PubMed ID: 26035383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-lymphangiogenesis effects of a specific anti-interleukin 7 receptor antibody in lung cancer model in vivo.
    Jian M; Qingfu Z; Yanduo J; Guocheng J; Xueshan Q
    Mol Carcinog; 2015 Feb; 54(2):148-55. PubMed ID: 24115038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of lymphangiogenesis: a new target for aspirin and other nonsteroidal anti-inflammatory agents? A systematic review.
    Yiannakopoulou E
    J Clin Pharmacol; 2012 Nov; 52(11):1749-54. PubMed ID: 22174438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of lymphangiogenesis: targets for blocking the metastatic spread of cancer.
    McColl BK; Loughran SJ; Davydova N; Stacker SA; Achen MG
    Curr Cancer Drug Targets; 2005 Dec; 5(8):561-71. PubMed ID: 16375662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tract.
    Langheinrich MC; Schellerer V; Perrakis A; Lohmüller C; Schildberg C; Naschberger E; Stürzl M; Hohenberger W; Croner RS
    Int J Clin Exp Pathol; 2012; 5(7):614-23. PubMed ID: 22977656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts.
    Hadler-Olsen E; Wetting HL; Rikardsen O; Steigen SE; Kanapathippillai P; Grénman R; Winberg JO; Svineng G; Uhlin-Hansen L
    Virchows Arch; 2010 Dec; 457(6):677-92. PubMed ID: 20890764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why and how do tumors stimulate lymphangiogenesis?
    Cao Y
    Lymphat Res Biol; 2008; 6(3-4):145-8. PubMed ID: 19093786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting tumor lymphangiogenesis: an update.
    Raica M; Ribatti D
    Curr Med Chem; 2010; 17(8):698-708. PubMed ID: 20088760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.